Molecular Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 11.4 | Q1 | 97.4% | 3.814 | Q1 | 98.5% |
| 2024 | 12.0 | Q1 | 97.9% | 4.008 | Q1 | 98.6% |
| 2023 | 12.1 | Q1 | 94.7% | 3.736 | Q1 | 98.6% |
| 2022 | 12.4 | Q1 | 94.6% | 3.425 | Q1 | 98.4% |
| 2021 | 12.9 | Q1 | 93.9% | 3.064 | Q1 | 98.1% |
| 2020 | — | — | 3.871 | Q1 | 98.6% | |
| 2019 | — | — | 3.489 | Q1 | 98.3% | |
| 2018 | — | — | 3.288 | Q1 | 98.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1525-0024
ISSN
1525-0016
region
Northern America
coverage
2000-2026